Ivica Ratosa, Angel Montero, Raquel Ciervide, Beatriz Alvarez, Mariola García-Aranda, Jeannette Valero, Xin Chen-Zhao, Mercedes Lopez, Daniel Zucca, Ovidio Hernando, Emilio Sánchez, Miguel Angel de la Casa, Rosa Alonso, Pedro Fernandez-Leton, Carmen Rubio
PURPOSE: Moderate hypofractionated radiotherapy is the standard of care for all patients with breast cancer, irrespective of stage or prior treatments. While extreme hypofractionation is accepted for early-stage tumours, its application in irradiating locoregional lymph nodes remains controversial. MATERIALS AND METHODS: A prospective registry analysis from July 2020 to September 2023 included 276 patients with early-stage breast cancer treated with one-week ultra-hypofractionation (UHF) at 26 Gy in 5 fractions on the whole breast (58...
May 2024: Clinical and Translational Radiation Oncology